Postdoctoral positions are available immediately to work in the areas of immunotherapy, microRNA, and cancer biology. The focus of the lab is on the interactions between radiation and oncogenic signaling pathways, microRNAs and the immune system. The approaches we use encompass mammalian cell culture, molecular biology, and mouse genetics. Our laboratory has a strong translational focus, with the goal of having most of our projects produce clinically relevant biomarkers or therapeutics for lung cancer within 3−4 years.

We are seeking candidates who are self-motivated and career-oriented to join our highly interactive research team. The University of Texas MD Anderson Cancer Center is ranked No. 1 in cancer care in the United States by U.S. News and World Report and “America’s Best Hospitals” survey. It also ranks first in the number of research grants awarded by the National Cancer Institute. MD Anderson offers active graduate and postdoctoral training programs and the unmatched scientific environment of the Texas Medical Center, the world’s largest biomedical center.

The University of Texas MD Anderson Cancer Center is an equal opportunity/affirmative action employer and does not discriminate on the basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas MD Anderson Cancer Center are security sensitive and subject to examination of criminal history record information, and MD Anderson is a smoke-free and drug-free environment.

This position will report to Dr. James Welsh, leader of the radiobiology group within the Heymach Laboratory at MD Anderson Cancer Center. Ideal applicants will have hands on experience in immunology and molecular oncology, command of written and spoken English language, and a prior publication record. Experience with mouse models is a plus.

中国-博士人才网发布